Disclaimer: This document is intended for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical judgment, diagnosis, or treatment. Clinicians must exercise their independent clinical judgment and consult with appropriate specialists when making patient care decisions. Information is subject to change based on evolving medical knowledge and guidelines. Always refer to the latest evidence-based guidelines and product information.

---

Larynx

Overview

• Definition: The larynx, commonly known as the voice box, is a cartilaginous organ located in the anterior neck, superior to the trachea and inferior to the pharynx. It serves three primary functions: airway protection during swallowing, respiration, and phonation (voice production). It houses the vocal cords.
• Epidemiology: Laryngeal disorders are common, with dysphonia (hoarseness) being a prevalent symptom affecting approximately 3-9% of the general population at any given time and up to 29% over a lifetime. Laryngeal cancer, while less common, accounts for about 1% of all cancers. Acute laryngitis is a very common condition, often viral.
• Classification:
  • Anatomical Regions:
    • Supraglottis: Above the vocal cords, including the epiglottis, aryepiglottic folds, arytenoids, and false vocal cords.
    • Glottis: Contains the true vocal cords and the anterior and posterior commissures.
    • Subglottis: Below the vocal cords, extending to the inferior border of the cricoid cartilage.
  • Functional:
    • Respiratory: Maintaining an open airway for breathing.
    • Protective: Preventing aspiration of food/liquid into the trachea.
    • Phonatory: Producing sound through vocal cord vibration.
  • Clinical Types of Laryngeal Disorders:
    • Inflammatory/Infectious: Laryngitis (acute/chronic), croup.
    • Neoplastic: Benign (nodules, polyps, papillomas, cysts) and malignant (squamous cell carcinoma).
    • Neurological: Vocal cord paralysis/paresis (unilateral/bilateral), spasmodic dysphonia.
    • Structural/Congenital: Laryngomalacia, laryngeal webs/stenosis.
    • Traumatic: External trauma, iatrogenic injury (e.g., post-intubation).
    • Functional: Muscle tension dysphonia.

Pathophysiology

• Mechanism:
  • Airway Protection: During swallowing, the larynx elevates and moves anteriorly, while the epiglottis folds posteriorly to cover the laryngeal inlet, preventing aspiration. The true vocal cords adduct tightly.
  • Respiration: The vocal cords abduct (open) to allow airflow into and out of the trachea and lungs.
  • Phonation: Voice is produced by the controlled exhalation of air from the lungs, which causes the true vocal cords to vibrate rapidly when adducted. The pitch, loudness, and quality of voice are modulated by tension, length, and mass of the vocal cords, and by the resonant properties of the pharynx, mouth, and nasal cavities. Laryngeal muscles (intrinsic and extrinsic) control vocal cord movement and tension.
• Risk Factors:
  • Environmental/Lifestyle:
    • Smoking (primary risk for laryngeal cancer, chronic laryngitis).
    • Alcohol consumption (synergistic with smoking for cancer risk).
    • Vocal abuse/misuse (excessive shouting, prolonged speaking, improper technique – leading to nodules, polyps, muscle tension dysphonia).
    • Gastroesophageal Reflux Disease (GERD) and Laryngopharyngeal Reflux (LPR) (can cause chronic inflammation, cough, dysphonia, globus sensation, increased risk of benign and potentially malignant lesions).
    • Exposure to irritants (dust, chemicals, fumes, allergens).
    • Dehydration.
  • Medical Conditions:
    • Upper respiratory tract infections (acute laryngitis).
    • Thyroid disease (recurrent laryngeal nerve compression or paresis).
    • Neurological disorders (Parkinson's disease, stroke, ALS, myasthenia gravis, central nervous system lesions affecting vagus nerve).
    • Autoimmune diseases (e.g., granulomatosis with polyangiitis, rheumatoid arthritis affecting cricoarytenoid joint).
    • Endotracheal intubation (trauma, granuloma formation, subglottic stenosis).
    • Immunosuppression (fungal or viral infections like HPV papillomatosis).
• Protective Factors:
  • Smoking cessation and avoidance of passive smoke.
  • Moderation of alcohol intake.
  • Good vocal hygiene (adequate hydration, avoidance of vocal strain, proper vocal technique, voice rest when hoarse).
  • Effective management of GERD/LPR.
  • Balanced diet and healthy lifestyle.
  • Vaccination against HPV (for papillomatosis, though typically less direct for laryngeal SCC compared to oropharyngeal).

Clinical Presentation

Signs and Symptoms

• Cardinal Features:
  • Dysphonia (Hoarseness): Most common symptom, involving changes in voice quality (roughness, breathiness, strain, weakness, loss of voice). Duration is critical for evaluation (persistent hoarseness > 2-3 weeks requires laryngoscopy).
  • Stridor: High-pitched, harsh inspiratory sound, indicating upper airway obstruction (critical sign).
• Early Signs:
  • Mild changes in voice quality (fatigue, slight raspiness).
  • Sore throat or discomfort in the throat.
  • Frequent throat clearing.
  • Mild globus sensation (feeling of a lump in the throat).
• Advanced Signs:
  • Severe dysphonia or aphonia (complete loss of voice).
  • Dyspnea (shortness of breath), especially with exertion.
  • Persistent odynophagia (painful swallowing) or dysphagia (difficulty swallowing).
  • Hemoptysis (coughing up blood).
  • Referred otalgia (ear pain, especially ipsilateral, often indicative of laryngeal malignancy).
  • Neck mass or swelling.
  • Unexplained weight loss.
• Atypical Presentations:
  • Chronic cough without other respiratory symptoms.
  • Choking or aspiration events without dysphagia.
  • Persistent globus sensation without reflux symptoms.
  • Difficulty projecting voice or vocal fatigue in professional voice users.

Physical Examination

• Inspection:
  • General: Observation of breathing pattern (stridor, retractions), neck contour, visible masses, skin changes.
  • Indirect Laryngoscopy: Using a laryngeal mirror to visualize the larynx. Limited by gag reflex, anatomy, and poor light.
  • Flexible Nasolaryngoscopy (Fiberoptic Laryngoscopy): Gold standard for office examination. A flexible scope is passed through the nostril into the pharynx, allowing real-time visualization of the nasal cavity, pharynx, and larynx. Assesses vocal cord mobility, mucosal lesions, inflammation, and pooling of secretions.
• Palpation:
  • Neck: Palpation of the anterior neck for masses, tenderness (e.g., thyroid cartilage, cricoid cartilage), and lymphadenopathy.
  • Laryngeal Crepitus: Gentle side-to-side movement of the thyroid cartilage over the cervical spine. Loss of crepitus can suggest a mass or fixation.
• Special Tests:
  • Laryngeal Stroboscopy: A specialized endoscopic technique that uses a flashing light synchronized with vocal fold vibration. This creates a slow-motion effect, allowing detailed assessment of vocal fold mucosal wave, amplitude, symmetry, and vibratory patterns – crucial for diagnosing benign lesions (e.g., nodules, polyps, cysts), scar, or early malignancy.
  • Voice Assessment: Perceptual voice assessment (e.g., GRBAS scale: Grade, Roughness, Breathiness, Asthenia, Strain), acoustic analysis (e.g., fundamental frequency, jitter, shimmer), aerodynamic measures (e.g., maximum phonation time, airflow rates).
  • Flexible Endoscopic Evaluation of Swallowing (FEES): Using a flexible endoscope to directly observe the pharyngeal and laryngeal phases of swallowing, assessing for aspiration and penetration, often used in dysphagia workup.

Diagnostic Approach

History Taking

• Key Questions:
  • Voice Symptoms: Onset, duration, progression, specific quality changes (hoarse, breathy, rough, strained, weak, aphonic). Is it constant or intermittent? Does it worsen with use?
  • Associated Symptoms: Pain (throat, ear), difficulty swallowing (solids/liquids, painful/non-painful), shortness of breath, cough, throat clearing, globus sensation, weight loss, fever, night sweats.
  • Risk Factors: Smoking history (pack-years), alcohol use, history of GERD/LPR symptoms (heartburn, regurgitation, bitter taste), vocal demands (professional voice user, teacher), exposure to irritants, history of intubation or neck surgery (e.g., thyroidectomy), recent URI.
  • Past Medical History: Neurological disorders, thyroid disease, autoimmune conditions, previous head/neck cancer.
  • Medications: Anticoagulants (risk of hemorrhage), steroids (candida), anticholinergics (drying effects).
• Red Flags:
  • Persistent dysphonia > 2-3 weeks (especially in smokers/drinkers).
  • Hemoptysis.
  • Unexplained weight loss.
  • Odynophagia or progressive dysphagia.
  • Referred otalgia.
  • Palpable neck mass.
  • Stridor or acute/progressive dyspnea.
  • History of head and neck cancer.

Laboratory Tests

• First-Line: Generally not required for direct laryngeal diagnosis unless a systemic cause is suspected.
  • CBC with differential: For infection or systemic inflammatory process.
  • Thyroid function tests (TSH, free T4): If thyroid pathology or recurrent laryngeal nerve involvement is suspected.
  • ANA, ANCA, ESR, CRP: If autoimmune/inflammatory conditions (e.g., granulomatosis with polyangiitis, rheumatoid arthritis) affecting the larynx are considered.
• Confirmatory:
  • Biopsy (obtained during laryngoscopy): Definitive diagnosis for neoplastic, granulomatous, or specific inflammatory conditions. Performed under direct laryngoscopy (usually rigid, under general anesthesia) for precise tissue sampling.
• Monitoring:
  • Specific serology/biomarkers: If related systemic conditions are being monitored (e.g., ANCA for GPA).

Imaging

• Recommended:
  • CT Scan of the Neck with IV Contrast: Excellent for evaluating the extent of laryngeal masses (especially cartilaginous invasion), lymphadenopathy, and soft tissue involvement. Useful for staging laryngeal cancer. Criteria: For evaluation of laryngeal masses, significant airway compromise, or suspected malignancy.
  • Barium Swallow/Videofluoroscopic Swallow Study (VFSS): If dysphagia or aspiration is a primary concern. Evaluates the oral, pharyngeal, and esophageal phases of swallowing and identifies structural abnormalities or physiological deficits.
• Advanced:
  • MRI of the Neck with Contrast: Provides superior soft tissue resolution compared to CT, particularly useful for subtle mucosal and submucosal lesions, perineural spread of malignancy, or assessment of vocal fold scarring.
  • PET-CT Scan: Primarily used for staging of laryngeal cancer (detection of distant metastases or regional nodal disease) and for surveillance in post-treatment settings. Not for primary diagnosis.
  • Chest X-ray/CT Chest: If pulmonary disease is suspected as a cause of cough, or for metastatic workup in laryngeal cancer.

Management

Acute Management

• Immediate:
  • Airway Management: For severe stridor or acute airway obstruction, immediate intervention is paramount.
    • Oxygen supplementation.
    • Heliox (80% helium, 20% oxygen): Can reduce work of breathing in upper airway obstruction.
    • Racemic Epinephrine nebulization (0.25-0.75 mL of 2.25% solution): For acute subglottic inflammation (e.g., croup).
    • Corticosteroids: Dexamethasone IV (e.g., 0.6 mg/kg, max 10 mg) for acute laryngeal edema or inflammation.
    • Intubation: If respiratory distress is severe and progressive. Prepare for potential difficult airway.
    • Emergency Tracheostomy/Cricothyrotomy: If intubation is impossible or contraindicated (e.g., severe laryngeal trauma, complete obstruction).
• Stabilization:
  • Acute Laryngitis: Voice rest (complete if severe), hydration, humidification, avoidance of irritants. Antibiotics only for bacterial infection (rarely indicated).
  • Acute Laryngeal Edema: Address underlying cause (allergy, angioedema, trauma). Antihistamines, corticosteroids.
• Emergency: See "Immediate" for airway crisis. Other emergencies include severe laryngeal trauma or acute hemorrhage.

Chronic Management

• Pharmacological:
  • Proton Pump Inhibitors (PPIs): For Laryngopharyngeal Reflux (LPR). E.g., Omeprazole 20-40 mg BID, 30-60 minutes before meals, typically for 2-3 months initially, then reassess. H2 blockers may be an alternative or adjunct (e.g., Famotidine 20 mg BID).
  • Corticosteroids (inhaled/oral): Occasionally used for chronic inflammatory conditions, but with caution due to side effects. Oral steroids for acute exacerbations of chronic inflammation or for short-term swelling reduction.
  • Antibiotics/Antifungals: For specific infections (e.g., bacterial tracheitis, laryngeal candidiasis).
  • Botulinum Toxin Injection: For spasmodic dysphonia (e.g., OnabotulinumtoxinA 1.25-5 units per vocal cord) or adductor laryngeal breathing dystonia. Injections are precise and guided electromyographically.
• Non-pharmacological:
  • Voice Therapy (Speech-Language Pathology): Cornerstone for many functional and benign organic laryngeal disorders (e.g., vocal nodules, muscle tension dysphonia, vocal fold paresis). Focuses on vocal hygiene, breath support, resonance, and reducing phonotrauma. Indications: Voice disorders not requiring immediate surgery or as an adjunct to surgical management.
  • Vocal Hygiene: Hydration, avoidance of caffeine/alcohol, smoking cessation, limit vocal abuse, humidification.
  • Reflux Precautions: Diet modification (avoiding trigger foods), elevation of bed head, avoiding eating 2-3 hours before bed.
  • Lifestyle Modifications: Smoking and alcohol cessation (critical for preventing and treating chronic laryngitis and cancer).
• Surgical:
  • Microlaryngoscopy and Biopsy/Excision: For diagnosis and removal of benign and early malignant lesions (e.g., vocal cord nodules, polyps, cysts, papillomas, early cancer). Performed under general anesthesia with microscopic precision.
  • Vocal Fold Injection Laryngoplasty: Injection of fillers (e.g., hyaluronic acid, calcium hydroxylapatite) into a paretic or atrophic vocal fold to improve glottic closure and voice quality.
  • Medialization Laryngoplasty (Thyroplasty): Surgical repositioning of the vocal fold (e.g., with an implant) to improve glottic closure in cases of persistent vocal cord paralysis.
  • Arytenoid Adduction: Surgical rotation of the arytenoid cartilage to improve glottic closure.
  • Laryngectomy (Partial or Total): For advanced laryngeal cancers. Partial laryngectomy aims to preserve voice and swallowing. Total laryngectomy removes the entire larynx, requiring a permanent tracheostomy and loss of natural voice (requiring alternative communication methods).
  • Tracheostomy: For long-term airway management in cases of irreversible upper airway obstruction or for airway protection (e.g., severe aspiration).
  • Laryngeal Reinnervation: Surgical reconnection of laryngeal nerves in select cases of vocal cord paralysis.
  • Dilation: For laryngeal or subglottic stenosis.

Treatment Algorithms

• First-Line (Persistent Hoarseness > 2-3 weeks):
  1. Comprehensive History & Physical Exam: Focus on risk factors, associated symptoms, voice characteristics.
  2. Flexible Nasolaryngoscopy: Essential for direct visualization of the larynx.
  3. Referral to Otolaryngologist (ENT Specialist): If visualization is unclear, if malignancy is suspected, or if hoarseness persists despite initial conservative measures.
  4. Consider Laryngeal Stroboscopy: If a voice disorder or mucosal lesion is suspected.
• Second-Line (After initial evaluation):
  1. Biopsy: If a suspicious lesion is identified.
  2. Imaging (CT/MRI): For staging or assessing extent of disease if malignancy or deep invasion is suspected.
  3. Voice Therapy: For functional voice disorders or benign lesions.
  4. Medical Management: For GERD/LPR.
• Refractory Cases:
  • Multidisciplinary Tumor Board: For persistent or recurrent laryngeal cancers.
  • Advanced Surgical Interventions: For complex structural issues or advanced disease.
  • Palliative Care: For advanced, incurable malignancies.
  • Voice and Swallowing Rehabilitation: Ongoing for significant functional deficits.

Complications

• Common:
  • Dysphonia/Aphonia: Persistent voice changes.
  • Chronic Cough/Throat Clearing.
  • Globus Sensation.
  • Vocal Fatigue.
• Serious:
  • Airway Obstruction: Stridor progressing to respiratory distress, potentially requiring intubation or tracheostomy.
  • Aspiration Pneumonia: Due to impaired laryngeal protection or vocal cord paralysis leading to chronic aspiration.
  • Spread of Malignancy: Regional lymph node metastases or distant metastases.
  • Recurrent Laryngeal Nerve Injury: Iatrogenic during neck surgery (e.g., thyroidectomy), leading to vocal cord paralysis.
• Long-term:
  • Permanent Voice Change/Loss: Post-surgical, post-radiation, or due to chronic disease.
  • Dysphagia: Chronic difficulty swallowing requiring dietary modifications or feeding tubes.
  • Tracheostomy Dependence: If permanent airway compromise.
  • Psychological Impact: Anxiety, depression due to voice changes, communication difficulties, or cancer diagnosis.
  • Laryngeal Stenosis: Narrowing of the airway, often due to chronic inflammation, intubation trauma, or surgical scarring.

Prognosis

• Factors:
  • Underlying Etiology: Acute laryngitis usually resolves completely. Benign lesions generally have excellent prognosis with appropriate treatment. Laryngeal cancer prognosis depends heavily on stage at diagnosis, tumor location, nodal involvement, distant metastases, and patient comorbidities.
  • Timeliness of Diagnosis and Treatment: Earlier detection and intervention often lead to better outcomes.
  • Patient Compliance: Adherence to voice therapy, reflux management, smoking cessation.
  • Vocal Demands: Professional voice users may have more difficulty regaining full vocal function.
  • Comorbidities: Systemic diseases (e.g., neurological, autoimmune, severe reflux) can complicate treatment and recovery.
• Survival:
  • Acute Laryngitis: Full recovery expected.
  • Benign Lesions: Generally excellent prognosis with resolution of symptoms following treatment.
  • Laryngeal Cancer:
    • Overall 5-year survival rate: Approximately 60-65%.
    • Stage I/II glottic cancer: 5-year survival rates can exceed 80-90% with timely treatment.
    • Advanced (Stage III/IV) cancer or supraglottic/subglottic involvement: Survival rates are significantly lower, often in the 30-50% range.
• Quality of Life: Can be significantly impacted by voice changes, swallowing difficulties, and the need for a tracheostomy. Multidisciplinary rehabilitation, including voice and swallowing therapy, is crucial to optimize quality of life.

Prevention

• Primary: Preventing initial occurrence of disease.
  • Smoking Cessation: The single most important preventive measure for laryngeal cancer and chronic laryngitis.
  • Moderation of Alcohol Intake.
  • Vocal Hygiene: Avoiding vocal abuse/misuse, maintaining hydration, proper vocal technique, voice rest during illness.
  • GERD/LPR Management: Dietary and lifestyle modifications, timely medical treatment.
  • Avoidance of Irritants: Minimize exposure to environmental pollutants, chemicals.
  • Vaccination: HPV vaccine may indirectly reduce risk of certain oropharyngeal and laryngeal cancers, and certainly prevents recurrent respiratory papillomatosis caused by HPV.
• Secondary: Early detection and intervention.
  • Prompt evaluation of persistent hoarseness: Any hoarseness lasting more than 2-3 weeks, especially in high-risk individuals (smokers, drinkers), warrants flexible nasolaryngoscopy.
  • Screening: No routine population screening for laryngeal cancer is recommended, but high-risk individuals should be counselled on symptoms and encouraged to seek early evaluation.
• Tertiary: Preventing complications and recurrence.
  • Adherence to Treatment Regimens: Completing radiation, chemotherapy, or voice therapy.
  • Post-treatment Surveillance: Regular follow-up with ENT specialist, including laryngoscopy, for cancer patients to detect recurrence early.
  • Rehabilitation: Voice and swallowing therapy to mitigate long-term functional deficits.
  • Ongoing Risk Factor Modification: Continued smoking/alcohol cessation, GERD management.

Special Populations

• Pediatric:
  • Unique Anatomy: Smaller, higher larynx, more pliable cartilage. Susceptible to airway compromise from edema.
  • Common Conditions:
    • Croup (Laryngotracheobronchitis): Most common cause of stridor in children, typically viral, characterized by barking cough, inspiratory stridor. Managed with corticosteroids (oral Dexamethasone 0.6 mg/kg single dose, max 10 mg) and racemic epinephrine for severe cases.
    • Laryngomalacia: Most common congenital laryngeal anomaly, causing inspiratory stridor, usually benign and self-resolving by 18-24 months. Severe cases may require supraglottoplasty.
    • Recurrent Respiratory Papillomatosis (RRP): Benign growths caused by HPV, can cause hoarseness and airway obstruction. Recurrent, requiring repeated surgical excision.
    • Subglottic Stenosis: Congenital or acquired (e.g., post-intubation). Can cause chronic stridor and recurrent croup-like symptoms.
• Geriatric:
  • Presbylaryngis (Vocal Cord Atrophy): Age-related changes leading to vocal fold bowing and incomplete glottic closure, resulting in breathy, weak voice. Managed with voice therapy or vocal fold injection laryngoplasty.
  • Increased prevalence of comorbidities: Neurological disorders (Parkinson's, stroke), thyroid disease, GERD, increasing risk of dysphonia and dysphagia.
  • Increased risk of laryngeal cancer.
  • Decreased laryngeal sensation: Higher risk of aspiration.
• Pregnancy:
  • Hormonal Changes: Can cause vocal fold edema, leading to dysphonia. Resolves postpartum.
  • Increased GERD/LPR: Due to hormonal changes and mechanical pressure from growing uterus. Management typically involves lifestyle/dietary changes and H2 blockers, with PPIs if severe and necessary.
  • Laryngeal masses: Papillomas can sometimes enlarge during pregnancy.
  • Airway Management: Careful consideration for intubation due to potential for mucosal edema and difficult airway.
• Comorbidities:
  • Neurological Disorders (e.g., Parkinson's Disease, Stroke): Can cause vocal cord paresis/paralysis, spasmodic dysphonia, or dysphagia. Management involves specialized voice therapy (e.g., LSVT LOUD for Parkinson's), botulinum toxin, or surgical intervention.
  • Autoimmune Diseases (e.g., Rheumatoid Arthritis, Granulomatosis with Polyangiitis): Can affect cricoarytenoid joints or cause laryngeal granulomas/stenosis. Requires systemic management of the underlying disease and local laryngeal interventions.
  • Renal Failure/Dialysis: Can contribute to chronic laryngitis due to electrolyte imbalances, fluid overload, or reflux.
  • Immunocompromised States: Increased risk of opportunistic infections (e.g., fungal laryngitis, CMV laryngitis).

Clinical Pearls

• Diagnostic:
  • "The Rule of 2-3 Weeks": Any patient with hoarseness lasting more than 2-3 weeks, especially a smoker or heavy drinker, must undergo direct visualization of the larynx (flexible nasolaryngoscopy). This is critical to rule out malignancy.
  • Persistent unilateral ear pain (otalgia), particularly in a smoker/drinker, with a normal otoscopic exam, should raise suspicion for laryngeal or hypopharyngeal cancer until proven otherwise (referred pain via cranial nerves IX and X).
  • Stridor is an emergency: Always address the airway first.
  • Laryngeal findings of posterior commissure erythema, pseudosulcus vocalis, or granuloma may suggest LPR.
• Treatment:
  • Voice rest for acute laryngitis is more effective than antibiotics.
  • Smoking cessation is the most impactful intervention for nearly all chronic laryngeal conditions exacerbated by smoking.
  • Voice therapy is often the primary treatment for benign vocal fold lesions and functional voice disorders; surgery is rarely the first line.
  • PPIs for LPR may require high doses (e.g., BID) and extended duration (2-3 months) for symptom resolution, and patient education on lifestyle changes is crucial.
• Pitfalls:
  • Missing a malignancy: Attributing persistent hoarseness in a high-risk patient to "laryngitis" or "reflux" without direct laryngeal visualization.
  • Delaying referral: Prolonged conservative management without ENT evaluation when red flags are present.
  • Over-reliance on antibiotics: For viral laryngitis or non-infectious causes of hoarseness.
  • Inadequate reflux management: Not recognizing LPR or providing insufficient treatment.

Recent Updates

• Guidelines:
  • AAO-HNSF Clinical Practice Guideline: Hoarseness (Dysphonia) (Update 2018): Emphasizes the 2-3 week rule for laryngeal visualization, advocates for patient education on vocal hygiene and reflux, and recommends voice therapy as a primary treatment modality.
  • NCCN Guidelines for Head and Neck Cancers: Continually updated recommendations for diagnosis, staging, and multidisciplinary treatment of laryngeal cancer, reflecting advances in radiation techniques, chemotherapy, and immunotherapy.
• Evidence:
  • Growing evidence supporting the use of high-speed digital imaging and laryngeal videostroboscopy for detailed functional assessment of the vocal folds, particularly for subtle mucosal wave abnormalities.
  • Increased understanding of the microbiome's role in chronic laryngeal inflammation, though therapeutic implications are still emerging.
  • Advancements in minimally invasive laryngeal surgery (e.g., transoral robotic surgery - TORS) for select early-stage laryngeal cancers, aiming for improved functional outcomes.
  • Emerging role of immunotherapy (e.g., PD-1 inhibitors) in recurrent or metastatic squamous cell carcinoma of the larynx, significantly improving prognosis in some patients.
• Controversies:
  • Optimal duration and dosing of PPIs for LPR: Debate on whether long-term maintenance therapy is always necessary or effective.
  • Role of screening for laryngeal cancer: Given low incidence and high false-positive rates, population screening is not recommended, but targeted screening for high-risk individuals remains an area of interest.
  • Management of unilateral vocal fold paralysis: Debate continues regarding the optimal timing and type of intervention (injection laryngoplasty vs. medialization laryngoplasty) and the role of reinnervation procedures.

Key References

• Guidelines:
  • American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) Clinical Practice Guideline: Hoarseness (Dysphonia) (Update 2018). Otolaryngol Head Neck Surg. 2018;158(1 suppl):S1-S42.
  • National Comprehensive Cancer Network (NCCN) Guidelines for Head and Neck Cancers. (Accessed via NCCN website, regularly updated).
• Studies:
  • Rosen CA, et al. Vocal fold nodules, polyps, and cysts: a review of the literature. Otolaryngol Head Neck Surg. 2000;123(5):548-554. (Landmark for benign vocal fold lesions)
  • Mauerer JT, et al. Laryngopharyngeal reflux: A comprehensive review of diagnosis and treatment. Laryngoscope. 2015;125 Suppl 1:S1-S17.
  • Clinical trials on immunotherapy (e.g., Pembrolizumab, Nivolumab) in recurrent/metastatic head and neck squamous cell carcinoma. (Refer to recent literature in NEJM, Lancet Oncology).
• Reviews:
  • Flint, P. W., Haughey, B. H., Robbins, K. T., et al. Cummings Otolaryngology: Head and Neck Surgery. 7th ed. Elsevier; 2021. (Comprehensive textbook)
  • Sataloff, R. T. Voice Science and Clinical Practice. Plural Publishing; 2017. (Specialized review for voice disorders)